Detection of Hepatitis B Virus Deoxyribonucleic Acid Using Real-Time Polymerase Chain Reaction Method in Pooled-Plasma Samples of Turkish Blood Donors

dc.authoridBerkem, Rukiye/0000-0002-7035-4723
dc.contributor.authorKarakoc, Ayse Esra
dc.contributor.authorBerkem, Rukiye
dc.contributor.authorBeyaz, Elif
dc.date.accessioned2025-01-27T20:24:26Z
dc.date.available2025-01-27T20:24:26Z
dc.date.issued2009
dc.departmentÇanakkale Onsekiz Mart Üniversitesi
dc.description.abstractBackground: The extent and the number of routine tests performed for blood donor screening to avoid infections transmitted through blood transfusion have been gradually increasing worldwide and is determined nationally. Following the publication of the new blood and blood components regulation, the blood banking and transfusion system is through a reorganization stage in Turkey. The national guideline including the donor screening algorithms is to be published which requires national data to be created. The aim of this study is to investigate HBV DNA in pooled plasma samples of blood donors in Turkey, which is a middle endemicity country for HBV infection. Study Design and Methods: Presence of HBV DNA was investigated using real-time polymerase chain reaction (RT-PCR) method in 187 pooled plasma samples prepared from 4484 blood donors, whose screening tests were found to be negative. The seropositivity for HBsAg of the blood donors in the study blood center is 2,2%,. Results: The rate of false-positivity of the RT-PCR method was found to be 1,6% for the mini pools and 0,04%, for the individual blood donors. HBV DNA was not detected in any of the donor bloods. Conclusion: The hospital blood centers in Turkey still have a high proportion of first time donors and replacement donors; also seropositivity of HBsAg in Turkish blood donors is high compared to Europe and US. Our data pointed to the high false positivity rate of RT PCR method which needs to be evaluated in creating national donor screening algorithms. (Clin. Lab. 2009;55:229-234)
dc.identifier.endpage234
dc.identifier.issn1433-6510
dc.identifier.issue5-6
dc.identifier.pmid19728557
dc.identifier.startpage229
dc.identifier.urihttps://hdl.handle.net/20.500.12428/22217
dc.identifier.volume55
dc.identifier.wosWOS:000269007900007
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherClin Lab Publ
dc.relation.ispartofClinical Laboratory
dc.relation.publicationcategoryinfo:eu-repo/semantics/openAccess
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_WoS_20250125
dc.subjectBlood donor screening
dc.subjecthepatitis B virus
dc.subjectnucleic acid amplification technology testing
dc.titleDetection of Hepatitis B Virus Deoxyribonucleic Acid Using Real-Time Polymerase Chain Reaction Method in Pooled-Plasma Samples of Turkish Blood Donors
dc.typeArticle

Dosyalar